A Study of Coagulation Changes at Early Stage after Total Knee Arthroplasty

Jian Huang; Peng Zhang; Dawei Wang

doi:10.1055/s-0038-1625957

The Journal of Knee Surgery, Table of Contents

J Knee Surg 2018; 31(09): 913-918
DOI: 10.1055/s-0038-1625957

Original Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Study of Coagulation Changes at Early Stage after Total Knee Arthroplasty

Jian Huang

¹Department of Orthopaedics, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong, People's Republic of China

,

Peng Zhang

¹Department of Orthopaedics, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong, People's Republic of China

,

Dawei Wang

¹Department of Orthopaedics, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong, People's Republic of China

› Author Affiliations

Abstract

Coagulation changes after total knee arthroplasty (TKA) can provide evidence for optimization of timing of perioperative anticoagulation medicine. To evaluate the changes, 50 patients with knee osteoarthritis or rheumatoid arthritis were recruited for the study and underwent thrombelastography tests pre-, 6 hours, 12 hours, and 24 hours after TKA surgery and Doppler ultrasound examination 20 to 24 hours after surgery. The results have shown prolonged clotting time (R value) at 6 and 12 hours, while shortened at 24 hours. Similar results have been found in combined clotting and coagulation time (R + K value). However, other parameters, such as coagulation time (K value), coagulation speed (α angle), maximum amplitude (MA), and coagulation index (CI), have not significantly changed except that CI has increased significantly at 24 hours. Further Doppler ultrasound examination did not detect any deep venous thrombosis in all patients. The data showed that coagulation time after TKA within 12 hours, especially within the 6-hour time period, after surgery was significantly higher, while at 24 hours it became lower than the preoperation time. The results suggested that anticoagulation medicine is not necessary during the first 6 to 12 hours, but is required between 12 and 24 hours after surgery to reduce the risk of thrombosis.

Keywords

coagulation changes - knee arthroplasty - coagulation index - Doppler ultrasound

Full Text

References

References
1 Zuckerman JD. Inpatient rehabilitation after total joint replacement. JAMA 1998; 279 (11) 880
2 Song K, Rong Z, Yao Y, Shen Y, Zheng M, Jiang Q. Metabolic syndrome and deep vein thrombosis after total knee and hip arthroplasty. J Arthroplasty 2016; 31 (06) 1322-1325
3 Levy YD, Hardwick ME, Copp SN, Rosen AS, Colwell Jr CW. Thrombosis incidence in unilateral vs. simultaneous bilateral total knee arthroplasty with compression device prophylaxis. J Arthroplasty 2013; 28 (03) 474-478
4 Shimoyama Y, Sawai T, Tatsumi S. , et al. Perioperative risk factors for deep vein thrombosis after total hip arthroplasty or total knee arthroplasty. J Clin Anesth 2012; 24 (07) 531-536
5 Miric A, Lombardi P, Sculco TP. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations. Am J Orthop 2000; 29 (04) 269-274
6 Guan ZP, Lü HS, Chen YZ, Song YN, Qin XL, Jiang J. Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty. Zhonghua Wai Ke Za Zhi 2005; 43 (20) 1317-1320
7 Pookarnjanamorakot C, Sirisriro R, Eurvilaichit C, Jaovisidha S, Koysombatolan I. The incidence of deep vein thrombosis and pulmonary embolism after total knee arthroplasty: the screening study by radionuclide venography. J Med Assoc Thai 2004; 87 (08) 869-876
8 Nathan S, Aleem MA, Thiagarajan P, Das De S. The incidence of proximal deep vein thrombosis following total knee arthroplasty in an Asian population: a Doppler ultrasound study. J Orthop Surg (Hong Kong) 2003; 11 (02) 184-189
9 Kim YH, Kim JS. Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br 2002; 84 (04) 566-570
10 Wang CJ, Wang JW, Chen LM, Chen HS, Yang BY, Cheng SM. Deep vein thrombosis after total knee arthroplasty. J Formos Med Assoc 2000; 99 (11) 848-853
11 Chung LH, Chen WM, Chen CF, Chen TH, Liu CL. Deep vein thrombosis after total knee arthroplasty in Asian patients without prophylactic anticoagulation. Orthopedics 2011; 34 (01) 15
12 Kimura K, Ohtani S, Okamura H, Ishii N, Kishimoto C, Konishi K. Anticoagulation therapy with heparin and warfarin in total knee arthroplasty for osteoarthritis knee. Clin Appl Thromb Hemost 2009; 15 (01) 109-112
13 Zimlich RH, Fulbright BM, Friedman RJ. Current status of anticoagulation therapy after total hip and total knee arthroplasty. J Am Acad Orthop Surg 1996; 4 (02) 54-62
14 Buckner TW, Leavitt AD, Ragni M. , et al. Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thromb Haemost 2016; 116 (01) 42-49
15 Barna L, Triplett DA. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions. Ric Clin Lab 1989; 19 (04) 345-354
16 Dudek MM, Kent N, Gustafsson KM, Lindahl TL, Killard AJ. Fluorescence-based blood coagulation assay device for measuring activated partial thromboplastin time. Anal Chem 2011; 83 (01) 319-328
17 Turi DC, Peerschke EI. Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies. Am J Clin Pathol 1986; 85 (01) 43-49
18 Despotis GJ, Santoro SA, Spitznagel E. , et al. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Anesthesiology 1994; 80 (02) 338-351
19 Dager WE, Gosselin RC, Kitchen S, Dwyre D. Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study. Ann Pharmacother 2012; 46 (12) 1627-1636
20 Daniels AH, Kawaguchi S, Contag AG. , et al. Hospital charges associated with “never events”: comparison of anterior cervical discectomy and fusion, posterior lumbar interbody fusion, and lumbar laminectomy to total joint arthroplasty. J Neurosurg Spine 2016; 25 (02) 165-169
21 Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or rotational thromboelastometry (ROTEM) to monitor haemostatic treatment in bleeding patients: a systematic review with meta-analysis and trial sequential analysis. Anaesthesia 2017; 72 (04) 519-531
22 Müller MC, Meijers JC, Vroom MB, Juffermans NP. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review. Crit Care 2014; 18 (01) R30
23 Dai Y, Lee A, Critchley LA, White PF. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg 2009; 108 (03) 734-742
24 Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012; 26 (01) 1-13
25 Bhardwaj V, Malhotra P, Hasija S, Chowdury UK, Pangasa N. Coagulopathies in cyanotic cardiac patients: an analysis with three point-of-care testing devices (Thromboelastography, rotational thromboelastometry, and sonoclot analyzer). Ann Card Anaesth 2017; 20 (02) 212-218
26 Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88 (02) 312-319
27 Franchi F, Hammad JS, Rollini F. , et al. Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists. J Thromb Thrombolysis 2015; 40 (01) 118-125
28 Bachli EB, Bösiger J, Béchir M. , et al. Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating system. Crit Care Res Pract 2011; 2011: 313854
29 Ti LK, Cheong KF, Chen FG. Prediction of excessive bleeding after coronary artery bypass graft surgery: the influence of timing and heparinase on thromboelastography. J Cardiothorac Vasc Anesth 2002; 16 (05) 545-550
30 Essell JH, Martin TJ, Salinas J, Thompson JM, Smith VC. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993; 7 (04) 410-415
31 Gonzalez E, Moore EE, Moore HB. Management of trauma-induced coagulopathy with thrombelastography. Crit Care Clin 2017; 33 (01) 119-134
32 Huang SY, Kim CY, Miller MJ. , et al. Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent. Am J Roentgenol 2013; 201 (01) 208-214
33 Perseghin P, Beverina I, Bongiorno U, Calvisi V, Branca A. Blood transfusion and deep venous thrombosis in primary total hip and knee replacement surgery: a retrospective analysis of 339 patients. Transfus Sci 1996; 17 (03) 397-406
34 Harbourne T, Nicolaides AN. Estimation of fibrinolytic activity of whole blood in patients with recurrent idiopathic deep venous thrombosis. J Vasc Surg 1986; 4 (01) 1-4
35 Törngren S. Prophylaxis of postoperative deep venous thrombosis. Studies on low-dose heparin, blood coagulation, infection as a risk factor and the half-life of fibrinogen in patients after gastrointestinal surgery. Acta Chir Scand Suppl 1979; 495: 1-69
36 Hartert H. Clinical studies on blood coagulation with thrombelastography. II. The thrombocytopathies. Dtsch Arch Klin Med 1952; 199 (03) 293-311
37 Hartert H. Thrombelastography, a method for physical analysis of blood coagulation. Z Gesamte Exp Med 1951; 117 (02) 189-203
38 Yang Y, Yao Z, Dai W, Shi P, Luo L, Zhang C. Changes of thrombelastography in patients undergoing elective primary total knee and total hip replacement with low molecular heparin prophylaxis. J Orthop Surg 2014; 9: 52